BioRegenx (BRGX) Financial Statements

24 Followers

BioRegenx Financial Overview

BioRegenx's market cap is currently $5.34M. The company's EPS TTM is $-0.0013; its P/E ratio is -4.23; BioRegenx is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 1.85M	$ 2.34M	$ 22.24K	$ 42.16K	$ 198.58K
Gross Profit	$ 1.50M	$ 1.66M	$ 16.31K	$ 36.23K	$ 198.03K
Operating Income	$ -518.99K	$ -22.76M	$ -110.00K	$ -78.31K	$ -165.00K
EBITDA	$ -443.92K	$ -22.76M	$ -557.07K	$ -72.38K	$ -161.00K
Net Income	$ -1.54M	$ -23.05M	$ -571.00K	$ -78.31K	$ -96.87K
Balance Sheet
Cash & Short-Term Investments	$ 69.38K	$ 58.40K	$ 125.40K	$ 676.00	$ 24.36K
Total Assets	$ 410.99K	$ 508.54K	$ 31.64K	$ 59.15K	$ 127.76K
Total Debt	$ 2.21M	$ 2.16M	$ 225.37K	$ 240.97K	$ 200.00K
Net Debt	$ 2.15M	$ 2.11M	$ 225.37K	$ 240.29K	$ 175.64K
Total Liabilities	$ 4.95M	$ 3.89M	$ 253.61K	$ 260.69K	$ 212.00K
Stockholders' Equity	$ -4.54M	$ -3.38M	$ -221.97K	$ -201.54K	$ -84.23K
Cash Flow
Free Cash Flow	$ 29.91K	$ -513.54K	$ -13.35K	$ -64.65K	$ -151.06K
Operating Cash Flow	$ 38.97K	$ -324.15K	$ -13.35K	$ -64.65K	$ -119.52K
Investing Cash Flow	$ -59.06K	$ -187.94K	$ 0.00	$ 0.00	$ -31.55K
Financing Cash Flow	$ 33.10K	$ 442.12K	$ 12.67K	$ 40.97K	$ 50.00K

Currency in USD

BioRegenx Earnings and Revenue History

Income Statement >

BioRegenx Debt to Assets

Balance Sheet >

BioRegenx Cash Flow

Cash Flow >

BioRegenx Forecast EPS vs Actual EPS

Earnings >